Medtech company Indigo Diabetes has closed its €38m (US$44.8m) Series B funding to help develop its glucose monitoring sensor for people with diabetes. The funding round was led by Fund+, with the participation of Ackermans & van Haaren, imec.xpand, Capricorn Digital Growth Fund, QBICII, Titan Baratto and the Series A investors. The company received strong…
©2023 All rights reserved LaingBuisson 
 Series B funding to help develop its glucose monitoring sensor for people with diabetes.){kind=link}